Giulia I Lane1, Ji Qi2, Ajith Dupati3, Stephanie Ferrante2, Rodney L Dunn2, Roshan Paudel4, Daniela Wittmann2, Lauren P Wallner5, Donna L Berry6, Chad Ellimoottil2, James E Montie2, J Quentin Clemens2. 1. Department of Urology, University of Michigan, Ann Arbor, MI; VA Ann Arbor Medical Center, Ann Arbor, MI. Electronic address: giuliala@med.umich.edu. 2. Department of Urology, University of Michigan, Ann Arbor, MI; VA Ann Arbor Medical Center, Ann Arbor, MI. 3. Wayne State University, School of Medicine, Detroit, MI. 4. Health Infrastructures and Learning Systems, University of Michigan, Ann Arbor, MI. 5. Department of Internal Medicine, University of Michigan, Ann Arbor, MI. 6. Biobehavioral Nursing and Health Informatics, University of Washington, Seattle, WA.
Abstract
OBJECTIVE: To evaluate whether completing a decision aid, Personal Patient Profile - Prostate (P3P), prior to prostatectomy, affects self-reported bother from post-prostatectomy urinary incontinence and erectile dysfunction. MATERIALS AND METHODS: This retrospective analysis included data from men with newly diagnosed clinically localized, very low to intermediate risk prostate cancer who elected for prostatectomy within the Michigan Urological Surgery Improvement Collaborative between 2018-2021. Multivariable logistic regression models were used to estimate the association between P3P use and bother from post prostatectomy erectile dysfunction and urinary incontinence as measured by the Expanded Prostate Cancer Index Composite (EPIC-26). RESULTS: Among the 3987 patients included, 7% used P3P (n = 266). Men who used P3P reported significantly less bother from erectile dysfunction at 6 months vs non-users (aOR 0.42 [95% CI 0.27-0.66]). At 12 months, the effect of P3P on bother from erectile dysfunction was not statistically significant (aOR 0.62 [95% CI 0.37-1.03]). Men who used P3P did not have a statistically significant difference in bother from urinary incontinence (3-month: aOR 0.56 [95% CI 0.30-1.06]; 6-month; aOR 0.79 [95% CI 0.31-1.97]). CONCLUSION: Within the stated limitations of this study, we find that use of a decision aid for localized prostate cancer was associated with decreased odds of men being bothered from sexual dysfunction but not urinary incontinence at 6 months post prostatectomy. Published by Elsevier Inc.
OBJECTIVE: To evaluate whether completing a decision aid, Personal Patient Profile - Prostate (P3P), prior to prostatectomy, affects self-reported bother from post-prostatectomy urinary incontinence and erectile dysfunction. MATERIALS AND METHODS: This retrospective analysis included data from men with newly diagnosed clinically localized, very low to intermediate risk prostate cancer who elected for prostatectomy within the Michigan Urological Surgery Improvement Collaborative between 2018-2021. Multivariable logistic regression models were used to estimate the association between P3P use and bother from post prostatectomy erectile dysfunction and urinary incontinence as measured by the Expanded Prostate Cancer Index Composite (EPIC-26). RESULTS: Among the 3987 patients included, 7% used P3P (n = 266). Men who used P3P reported significantly less bother from erectile dysfunction at 6 months vs non-users (aOR 0.42 [95% CI 0.27-0.66]). At 12 months, the effect of P3P on bother from erectile dysfunction was not statistically significant (aOR 0.62 [95% CI 0.37-1.03]). Men who used P3P did not have a statistically significant difference in bother from urinary incontinence (3-month: aOR 0.56 [95% CI 0.30-1.06]; 6-month; aOR 0.79 [95% CI 0.31-1.97]). CONCLUSION: Within the stated limitations of this study, we find that use of a decision aid for localized prostate cancer was associated with decreased odds of men being bothered from sexual dysfunction but not urinary incontinence at 6 months post prostatectomy. Published by Elsevier Inc.
Authors: Donna L Berry; Fangxin Hong; Traci M Blonquist; Barbara Halpenny; Christopher P Filson; Viraj A Master; Martin G Sanda; Peter Chang; Gary W Chien; Randy A Jones; Tracey L Krupski; Seth Wolpin; Leslie Wilson; Julia H Hayes; Quoc-Dien Trinh; Mitchell Sokoloff; Prabhakara Somayaji Journal: J Urol Date: 2017-07-25 Impact factor: 7.450
Authors: Zvi Symon; Stephanie Daignault; Rachel Symon; Rodney L Dunn; Martin G Sanda; Howard M Sandler Journal: Urology Date: 2006-12-04 Impact factor: 2.649
Authors: David J Einstein; Dattatraya Patil; Jonathan Chipman; Meredith M Regan; Kyle Davis; Catrina M Crociani; Andrew A Wagner; Martin G Sanda; Peter Chang Journal: Urology Date: 2019-02-18 Impact factor: 2.649
Authors: Maryam Derogar; Hanna Dahlstrand; Stefan Carlsson; Anders Bjartell; Jonas Hugosson; Elin Axén; Eva Johansson; Mikael Lagerkvist; Tommy Nyberg; Johan Stranne; Thordis Thorsteinsdottir; Anna Wallerstedt; Eva Haglind; Peter Wiklund; Gunnar Steineck Journal: Acta Oncol Date: 2016-08-16 Impact factor: 4.089
Authors: Maarten Cuypers; Romy E D Lamers; Paul J M Kil; Lonneke V van de Poll-Franse; Marieke de Vries Journal: Trials Date: 2015-05-27 Impact factor: 2.279
Authors: Nnenaya Agochukwu-Mmonu; Jonathan B Wiseman; Abigail R Smith; Margaret E Helmuth; Aruna V Sarma; Anne P Cameron; Cindy L Amundsen; Kathryn E Flynn; David Cella; Kevin P Weinfurt; Ziya Kirkali; J Quentin Clemens Journal: Neurourol Urodyn Date: 2020-08-06 Impact factor: 2.696
Authors: Gregory B Auffenberg; Ji Qi; Rodney L Dunn; Susan Linsell; Tae Kim; David C Miller; Jeffrey Tosoian; Richard Sarle; William K Johnston; Eduardo Kleer; Khurshid R Ghani; James Montie; James Peabody Journal: JAMA Surg Date: 2021-03-10 Impact factor: 14.766